Modeling breath-enhanced jet nebulizers to estimate pulmonary drug deposition

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 26, Issue 6, 2013, Pages 387-396

  Wee, Wallace B ^a,b   Leung, Kitty ^a   Coates, Allan L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bench testing; Modeling; Nebulizer; Other; Ventilation

Indexed keywords

ARTICLE; BREATH ENHANCED JET NEBULIZER; BREATHING PATTERN; BREATHING RATE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; FEASIBILITY STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSPIRATION TO EXPIRATION TIME; LUNG DEAD SPACE; MATHEMATICAL MODEL; MEDICAL NEBULIZER; PARTICLE SIZE; PHARMACOLOGICAL PARAMETERS; PREDICTION; PULMONARY DRUG DEPOSITION; RESPIRATORY TRACT PARAMETERS; STEADY STATE; TIDAL VOLUME;

ADMINISTRATION, INHALATION; AEROSOLS; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; EQUIPMENT DESIGN; HUMANS; LUNG; MODELS, BIOLOGICAL; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RESPIRATION; RESPIRATORY MECHANICS; RESPIRATORY SYSTEM AGENTS; TIME FACTORS;

EID: 84884132093     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2012.0984     Document Type: Article

References (31)

1. Leung K, Louca E, and Coates AL: Comparison of breath enhanced to breath actuated nebulizers for rate, consistency and efficiency. Chest. 2004;26:1619-1627.
2. Ho SL, Kwong WTJ, and Coates AL: Evaluation of four breath-enhanced nebulizers for home use. J Aerosol Med. 2001;14:467-475. (Pubitemid 34008103)
3. Coates AL, MacNeish CF, Allen PD, Ho SL, and Lands LC: Do sinusoidal models of respiration accurately reflect the respiratory events of cystic fibrosis patients breathing on nebulizers? J Aerosol Med. 1999;12:265-273.
4. Bosco AP, Rhem RG, and Dolovich MB: In vitro estimations of in vivo jet nebulizer efficiency using actual and simulated tidal breathing patterns. J Aerosol Med. 2005;18:427-438. (Pubitemid 43038408)
5. Coates AL, Green M, Leung K, Chan J, Ribeiro N, Louca E, Ratjen F, Charron M, Tservistas M, and Keller M: Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: a pilot project. Pediatr Pulmonol. 2008;43:753-759.
6. Coates AL, Green M, Leung K, Louca E, Tservistas M, Chan J, Ribeiro N, and Charron M: The challenges of quantitative measurement of lung deposition using 99mTc-DTPA from delivery systems with very different delivery times. J Aerosol Med. 2007;20:320-330. (Pubitemid 47463185)
7. Katz SL, Ho SL, and Coates AL: Nebulizer choice for treatment of cystic fibrosis patients with inhaled colistin. Chest. 2001;119:250-255. (Pubitemid 32150575)
8. Ramsey BW, Dorkin HL, Eisenberg JD, and Gibson RL: Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med. 1993;328:1740-1746. (Pubitemid 23170123)
9. Geller DE, Pitlick WH, Nardella PA, Tracewell WG, and Ramsey BW: Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis. Chest. 2002;122:219-226. (Pubitemid 34754166)
10. Deterding RR, Lavange LM, Engels JM, Mathews DW, Coquillette SJ, Brody AS, Millard SP, and Ramsey BW: Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis. Am J Respir Crit Care Med. 2007;176:362-369. (Pubitemid 47267470)
11. O'Callaghan C, Clarke AR, and Milner AD: Inaccurate calculation of drug output from nebulisers. Eur J Pediatr. 1989;148:473-474. (Pubitemid 19049335)
12. Evans ME, Walker SR, Brittain RT, and Paterson JW: The metabolism of salbutamol in man. Xenobiotica. 1973;3:113-120.
13. Coates AL, MacNeish CF, Lands LC, Meisner D, Kelemen S, and Vadas EB: A comparison of the availability of tobramycin for inhalation from vented versus unvented nebulizers. Chest. 1998;113:951-956. (Pubitemid 28216437)
14. Kwong E, MacNeish CF, Meisner D, Kelemen S, Vadas EB, and Coates AL: The use of osmometry as a means of determining changes in drug concentration during jet nebulization. J Aerosol Med. 1998;11:89-100. (Pubitemid 28259489)
15. MacNeish CF, Meisner D, Thibert R, Kelemen S, Vadas EB, and Coates AL: A comparison of pulmonary availability between Ventolin (albuterol) nebules and Ventolin (albuterol) Respirator Solution. Chest. 1997;111:204-208. (Pubitemid 27043631)
16. Kwong WTJ, Ho SL, and Coates AL: Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor. J Aerosol Med. 2000;13:303-314. (Pubitemid 32105616)
17. Mitchell JP, Nagel MW, Nichols S, and Nerbrink O: Laser diffractometry as a technique for rapid assessment of aerosol particle size from inhalers. J Aerosol Med. 2006;19:409-433. (Pubitemid 46067762)
18. Clark AR: The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers. Int J Pharm. 1995;115:69-78.
19. Coates AL, MacNeish CF, Dinh L, Rollin T, Gagnon S, Ho SL, and Lands LC: Accounting for radioactivity before and after nebulization of tobramycin to insure accuracy of quantification of lung deposition. J Aerosol Med. 2000;13:169-178.
20. Chernick V, and West JB: The functional basis of respiratory disease. In: V Chernick, TE Boat, RW Wilmott, and A Bush, (eds). Kendig's Disorders of the Respiratory Tract in Children. Saunders/Elsevier, Philadelphia, PA; pp. 29-64, 2006.
21. Bland JM, and Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310. (Pubitemid 16134762)
22. Cherniack N, Vosti KL, Saxton GA, Lepper MH, and Dowling HF: Pulmonary function tests in fifty patients with bronchiectasis. J Lab Clin Med. 1959;53:693-707.
23. Coates AL, Denk O, Leung K, Ribeiro N, Chan J, Green M, Martin S, Charron M, Edwardes M, and Keller M: Higher tobramycin concentration and vibrating mesh technology can shorten antibiotic treatment time in cystic fibrosis. Pediatr Pulmonol. 2011;46:401-408.
24. Fleming JS, Epps BP, Conway JH, and Martonen TB: Comparison of SPECT aerosol deposition data with a human respiratory tract model. J Aerosol Med. 2006;19:268-278. (Pubitemid 44735385)
25. Hess D, Fisher D, Williams P, Pooler S, and Kacmarek RM: Medication nebulizer performance: effects of diluent volume, nebulizer flow and nebulizer brand. Chest. 1996;110:498-505. (Pubitemid 26269284)
26. Chatburn RL, and McPeck M: A new system for understanding nebulizer performance. Respir Care. 2007;52:1037-1050.
27. Finlay WH, Stapleton KW, Chan H-K, Zuberbuhler P, and Gonda I: Regional deposition of inhaled hygroscopic aerosols: in vivo SPECT compared with mathematical model. J Appl Physiol. 1996;82:374-383. (Pubitemid 26255533)
28. Weers J, Metzheiser B, Taylor G, Warren S, Meers P, and Perkins WR: A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers. J Aerosol Med Pulm Drug Deliv. 2009;22:131-138.
29. Tiddens HAM, Geller DE, Challoner P, Speirs RJ, Kesser KC, Overbeek SE, Humble D, Shrewbury SB, and Standaert TA: Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older. J Aerosol Med. 2006;19:456-465. (Pubitemid 46067764)
30. Corcoran TE, Venkataramanan R, Mihelc KM, Marcinkowski AL, Ou J, McCook BM, Weber L, Carey ME, Paterson DL, Pilewski JM, McCurry KR, and Husain S: Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients. Am J Transplant. 2006;6:2765-2773. (Pubitemid 44571699)
31. Heyder J, Gebhart J, Rudolf G, Schiller CF, and Stahlhofen W: Deposition of particles in the human respiratory tract in the size range 0.005-15 lm. J Aerosol Sci. 1986;17:811-825. (Pubitemid 17492310)